Hosted on MSN11h
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip
Eli Lilly and Company LLY dropped 6.6% in the Jan. 14 trading session after slashing its revenue guidance for the fourth quarter and fiscal 2024, citing lower-than-expected sales for its weight-loss ...
Eli Lilly & Co.: Positive Long-Term Outlook Despite Recent Setbacks – Buy Rating Affirmed
Analyst Mohit Bansal from Wells Fargo maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) and keeping the price target at ...
GlobalData on MSN15h
JP Morgan 2025: Eli Lilly misses 2024 revenue estimate by $400m
Eli Lilly’s CEO Dave Ricks cited stocking levels and unexpected market dynamics in Q4 2024 in the GLP-1RA market.
MM&M2d
Obesity meds to lead charge as pharma sales ride ‘momentum’ into 2025
While obesity product sales will be driving the boon in 2025, industry experts are also eyeing promising new launches in ...
Eli Lilly & Co: Strong Growth Prospects and Strategic Positioning Justify Buy Rating
Eli Lilly & Co (LLY – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Evan ...
FiercePharma12d
Roche projected to claim pharma's 2025 sales crown as Novo, Lilly climb rankings: Evaluate
The story of Eli Lilly and Novo Nordisk’s GLP-1 dominance is likely to play out again in 2025 as the metabolic medicine ...
Novo, Eli Lilly to dominate global pharma sales in 2025: report
Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...
Yahoo Finance1mon
Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt
Under this agreement, Lilly has been supplying its active pharmaceutical ingredient (API) for insulin to EVA Pharma at a significantly reduced price and providing pro-bono technology transfer to ...
Reuters21d
Approvals News | Today's Latest Stories | Reuters
US FDA says Lilly's weight-loss drug shortage is resolved Healthcare & Pharmaceuticalscategory· December 19, 2024 The U.S. Food and Drug Administration has approved Ionis Pharmaceuticals' drug to ...
Seeking Alpha27d
Zealand Pharma And Eli Lilly: Strategic Focus On Weight Management And Future Outlook
However, given the developmental stage of the products I will focus on the ... to date financial highlights comparing Zealand Pharma vs. Eli Lilly. Please note, Zealand's figures are in DKK ...